Background and aims: Berberine (BBR) is an isoquinoline derivative alkaloid isolated from Rhizoma Coptidis traditionally used as anti diarrheic and, more recently, as hypolipidemic and insulin sensitizer agent. Thus, BBR could represent a potential therapeutic option for patients with polycystic ovary syndrome (PCOS). The aim of this study was to evaluate the clinical, metabolic and hormonal effects of BBR in PCOS women. Methods: Fifty oligoamenorrheic PCOS obese women and 50 age and Body Mass Index (BMI) matched healthy controls were enrolled. PCOS women received BBR treatment (500mg, 2 times daily) for 6 months. Clinical and biochemical parameters were assessed before and after the treatment period. Results: Total testosterone (p<0.01), free androgen index (p<0.01), androstenedione (p<0.01), sex hormone binding globulin (p<0.01), progesterone (p<0.01), total cholesterol (p=0.01), low density lipoprotein cholesterol (p<0.01), triglycerides (p<0.01), area under the curve of insulin (p<0.01), menses frequency (p<0.01) and Waist Circumference (p=0.04) significantly (p<0.05) improved after BBR treatment. No correlation was found between variations of insulin sensitivity and hormonal changes. Conclusions: BBR improves clinical, metabolic and reproductive features in PCOS women. Its mechanism of actions need to be elucidated in further studies. © 2013 European Society for Clinical Nutrition and Metabolism.

Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity / Orio, Francesco; Muscogiuri, Giovanna; Palomba, Stefano; Savastano, Silvia; Volpe, Alessio; Orio, Marcello; Colarieti, Giorgio; LA SALA, Giovanni Battista; Colao, Annamaria; Marciano, Francesca; Ascione, Antonio; Putignano, Pietro. - In: E-SPEN JOURNAL. - ISSN 2212-8263. - 8:5(2013), pp. e200-e204. [10.1016/j.clnme.2013.07.002]

Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity

Palomba, Stefano;LA SALA, Giovanni Battista;
2013

Abstract

Background and aims: Berberine (BBR) is an isoquinoline derivative alkaloid isolated from Rhizoma Coptidis traditionally used as anti diarrheic and, more recently, as hypolipidemic and insulin sensitizer agent. Thus, BBR could represent a potential therapeutic option for patients with polycystic ovary syndrome (PCOS). The aim of this study was to evaluate the clinical, metabolic and hormonal effects of BBR in PCOS women. Methods: Fifty oligoamenorrheic PCOS obese women and 50 age and Body Mass Index (BMI) matched healthy controls were enrolled. PCOS women received BBR treatment (500mg, 2 times daily) for 6 months. Clinical and biochemical parameters were assessed before and after the treatment period. Results: Total testosterone (p<0.01), free androgen index (p<0.01), androstenedione (p<0.01), sex hormone binding globulin (p<0.01), progesterone (p<0.01), total cholesterol (p=0.01), low density lipoprotein cholesterol (p<0.01), triglycerides (p<0.01), area under the curve of insulin (p<0.01), menses frequency (p<0.01) and Waist Circumference (p=0.04) significantly (p<0.05) improved after BBR treatment. No correlation was found between variations of insulin sensitivity and hormonal changes. Conclusions: BBR improves clinical, metabolic and reproductive features in PCOS women. Its mechanism of actions need to be elucidated in further studies. © 2013 European Society for Clinical Nutrition and Metabolism.
2013
8
5
e200
e204
Berberine improves reproductive features in obese Caucasian women with polycystic ovary syndrome independently of changes of insulin sensitivity / Orio, Francesco; Muscogiuri, Giovanna; Palomba, Stefano; Savastano, Silvia; Volpe, Alessio; Orio, Marcello; Colarieti, Giorgio; LA SALA, Giovanni Battista; Colao, Annamaria; Marciano, Francesca; Ascione, Antonio; Putignano, Pietro. - In: E-SPEN JOURNAL. - ISSN 2212-8263. - 8:5(2013), pp. e200-e204. [10.1016/j.clnme.2013.07.002]
Orio, Francesco; Muscogiuri, Giovanna; Palomba, Stefano; Savastano, Silvia; Volpe, Alessio; Orio, Marcello; Colarieti, Giorgio; LA SALA, Giovanni Batt...espandi
File in questo prodotto:
File Dimensione Formato  
Orio F 2013 e-SPEN J.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 221.59 kB
Formato Adobe PDF
221.59 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1118263
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 18
  • ???jsp.display-item.citation.isi??? ND
social impact